Recombinant Human IGF-1 (Insulin-Like Growth Factor) Therapy: Where Do We Stand Today?

The GH-IGF1 axis and longevity. The paradigm of IGF1 deficiency

(2014) Zvi Laron   Hormones-International Journal of Endocrinology and Metabolism

Congenital IGF1 deficiency tends to confer protection against post-natal development of malignancies

(2011) Rachel Steuerman et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Atypical subtrochanteric and diaphyseal femoral fractures: Report of a task force of the american society for bone and mineral Research

(2010) Elizabeth Shane et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Growth Hormone and Health Policy

(2010) Leona Cuttler et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Recombinant Insulin-Like Growth Factor (IGF)-I Treatment in Short Children with Low IGF-I Levels: First-Year Results from a Randomized Clinical Trial

(2009) L. Kurt Midyett et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

The Role of Recombinant Human Insulin-Like Growth Factor-I in Treating Children with Short Stature

(2007) Paulo F. Collett-Solberg et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM